NUMD · Nu-Med Plus, Inc.
$0.02
+0.00 (+0.00%)
At close · Jul 29
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“If plans to obtain further financing prove to be insufficient to fund operations, continued viability could be at risk. These factors raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed May 14, 2026
Market Cap
$1.54M
Shares
83.55M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$0
FY2020
Net Income
-$56.18K
+17.8%
FY2025
Diluted EPS
$0.00
FY2025
Operating Cash Flow
-$47.98K
-982.3%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| — | — | -$5000 | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | — | $66.21K | — | |
| $23.12K | $34.32K | $27.56K | $26.57K | $32.28K | $58.26K | $76.13K | $128.1K | $64.97K | $62.17K | $39.47K | $60.17K | $34.22K | $13.68K | |
| — | — | $2267 | $2267 | $9365 | $11.79K | $13.37K | $14.74K | $12.54K | — | $7149 | $6964 | $5031 | — | |
| $48.96K | $63.33K | $120.53K | $182.17K | $839.45K | $1.99M | $1.02M | $1.17M | $466.52K | $1.22M | $951.06K | $1.15M | $495.51K | — | |
| -$48.96K | -$63.33K | -$120.53K | -$182.17K | -$839.45K | -$1.99M | -$1.02M | -$1.17M | -$466.52K | -$1.22M | -$951.06K | -$1.15M | -$495.51K | -$261.87K | |
| — | — | -$118.26K | -$179.9K | -$830.08K | -$1.98M | -$1.01M | -$1.15M | -$453.98K | — | -$943.91K | -$1.14M | -$490.47K | — | |
| $7227 | $5014 | — | $1000 | $14.32K | $14.32K | -$17.41K | -$19.54K | -$18.88K | -$15.91K | -$16.95K | -$46.62K | -$103.19K | $4535 | |
| — | — | — | — | — | $0 | $11 | $101 | $122 | $7 | $7 | $13 | $19 | $18 | |
| -$7227 | -$5014 | — | — | — | — | — | — | — | — | — | — | — | — | |
| -$56.18K | -$68.35K | -$125.53K | -$130.17K | — | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | $0 | $0 | $100 | $0 | $0 | $0 | $0 | $0 | $0 | |
| -$56.18K | -$68.35K | -$125.53K | -$130.17K | -$830.06K | -$2.01M | -$1.04M | -$1.19M | $3.58M | $9.65M | -$1.11M | -$1.19M | -$598.68K | -$266.39K | |
| USD/shares | $0.00 | $0.00 | $0.00 | $0.00 | -$0.01 | -$0.04 | -$0.02 | -$0.03 | $0.10 | $0.26 | — | — | — | — |
| USD/shares | $0.00 | $0.00 | $0.00 | $0.00 | -$0.01 | -$0.04 | -$0.02 | -$0.03 | $0.05 | $0.13 | — | — | — | — |
| shares | 83.55M | 83.55M | 81.67M | 79.95M | 73.37M | 54.51M | 45.55M | 41.79M | 37.46M | 37.22M | 35.4M | 32.79M | 27.82M | 22.64M |
| shares | 83.55M | 83.55M | 81.67M | 79.95M | 73.37M | 54.51M | 45.55M | 41.79M | 71.86M | 75.03M | — | — | — | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Key facts
CIK
1543637
CUSIP
67021R104